Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Iteos Therapeutics Inc (ITOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2021	06-2021	03-2021	12-2020	09-2020
Cash Flows From Operating Activities
Net Income	29,649	-39,993	-13,534	-38,033	-23,129
Depreciation Amortization	452	276	126	535	392
Accounts receivable	-5,025	-4,112	-958	5,033	2,502
Accounts payable and accrued liabilities	1,763	8,265	2,348	1,677	901
Other Working Capital	532,102	861	-3,966	9,330	2,051
Other Operating Activity	13,015	1,658	1,194	-3,718	-2,429
Operating Cash Flow	$571,956	$-33,045	$-14,790	$-25,176	$-19,712

Cash Flows From Investing Activities
Change In Deposits	-62	-60	-3	-21	-21
PPE Investments	-1,019	-489	-88	-356	-222
Investing Cash Flow	$-1,081	$-549	$-91	$-377	$-243

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	N/A	N/A	4,046	2,856
Common Stock Issued	1,303	862	667	214,315	214,315
Other Financing Activity	0	0	0	121,978	122,335
Financing Cash Flow	$1,303	$862	$667	$340,339	$339,506

Exchange Rate Effect	-8,728	-650	-717	1,678	566
Beginning Cash Position	336,454	336,454	336,454	19,990	19,990
End Cash Position	899,904	303,072	321,523	336,454	340,107
Net Cash Flow	$563,450	$-33,382	$-14,931	$316,464	$320,117

Free Cash Flow
Operating Cash Flow	571,956	-33,045	-14,790	-25,176	-19,712
Capital Expenditure	-1,019	-489	-88	-356	-222
Free Cash Flow	570,937	-33,534	-14,878	-25,532	-19,934